Jump to content

David Jenkins (sprinter)

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jonas kam (talk | contribs) at 02:58, 26 June 2007. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Olympic medal record
Men’s Athletics
Silver medal – second place 1972 Munich 4x400 metre relay

David Jenkins (born 25 May,1952) was a Scottish athlete who competed mainly in the 400 metres. He was later convicted of drug offences.

Jenkins was educated at Edinburgh Academy, where he excelled at sport. In 1971, aged only nineteen, Jenkins won the 400 meters at the European Athletics Championships in Helsinki. He competed for Great Britain in the 1972 Summer Olympics held in Munich, Germany in the 4 x 400 metre relay where he won the silver medal with his team mates Martin Reynolds, Alan Pascoe and David Hemery. In 1974 he won the silver medal on the 400 meters at the European Athletics Championships in Rome as well as the gold medal in the 4x 400 metre with his team mates Glendon Cohen, William Hartley and Alan Pascoe. In 1976 and 1980 Jenkins placed 7th on the 400 metre at the Summer Olympics.

He later admitted to having taken performance-enhancing steroids during his athletics career.

In the 80s Jenkins together with Juan Javier Macklis foundet a company for production of anabol steroids in Mexiko which they wanted to sell on the US market. Jenkins was arrested by the police and in December 1988 found guilty by an US court of trafficking anabol steroids worth around 100 Million dollar. He was sentenced to seven years in the Mojave Desert Jail, but was released after 9 months. In 1993 he and his partner Dan Duchaine, a well known steroid guru, foundet Next Nutrition, a company which produced dietary supplements for athletes and bodybuilders. When Duchaine died Jenkins became the chairman of Next Nutrition. [1]

Today he lives in San Diego, California.

References

  1. ^ Alessandro Donati: World Traffic in Doping Substances WADA, Februar 2007, p. 30, (Pdf, 542 KB)